Clinical Trial Update: Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel poliglumex in combination with capecitabine in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Paclitaxel poliglumex (paclitaxel poliglumex)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED